MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases.
about
Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal MedicineProteomics and peptidomics: moving toward precision medicine in urological malignanciesThe use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.Liquid biopsy: a step forward towards precision medicine in urologic malignancies.Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
P2860
MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MALDI MS profiling of post-DRE ...... marker for prostatic diseases.
@ast
MALDI MS profiling of post-DRE ...... marker for prostatic diseases.
@en
type
label
MALDI MS profiling of post-DRE ...... marker for prostatic diseases.
@ast
MALDI MS profiling of post-DRE ...... marker for prostatic diseases.
@en
prefLabel
MALDI MS profiling of post-DRE ...... marker for prostatic diseases.
@ast
MALDI MS profiling of post-DRE ...... marker for prostatic diseases.
@en
P2093
P2860
P356
P1433
P1476
MALDI MS profiling of post-DRE ...... marker for prostatic diseases
@en
P2093
Brian Flatley
Karen G Wilmott
Peter Malone
P2860
P304
P356
10.1002/PROS.22736
P577
2013-09-30T00:00:00Z